INDSWFTLAB — IND Swift Laboratories Cashflow Statement
0.000.00%
- IN₹4.56bn
- IN₹343.75m
- IN₹12.81bn
- 43
- 93
- 13
- 49
Annual cashflow statement for IND Swift Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -198 | 180 | 125 | 1,132 | 1,952 |
Depreciation | |||||
Non-Cash Items | 860 | 921 | 946 | 754 | 715 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -310 | -624 | -879 | -513 | -5,012 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | 1,252 | 1,349 | 1,503 | 1,946 | -1,813 |
Capital Expenditures | -112 | -44 | -184 | -128 | -445 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 20.7 | -57.8 | 232 | -5.98 | -598 |
Sale of Fixed Assets | |||||
Change in Net Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -91 | -102 | 47.7 | -134 | -1,043 |
Financing Cash Flow Items | -675 | -839 | -1,049 | -1,285 | 8,092 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | -1,333 | -1,237 | -1,409 | -1,857 | 6,989 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -194 | 10.2 | 142 | -44.1 | 4,133 |